Prevalence of cervical human papillomavirus and the risk of anal co-infection in kidney transplant recipients: Results from a Danish clinical study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Prevalence of cervical human papillomavirus and the risk of anal co-infection in kidney transplant recipients : Results from a Danish clinical study. / Ring, Linea Landgrebe; Thomsen, Louise T.; Hædersdal, Merete; Sørensen, Søren Schwartz; Bonde, Jesper Hansen; Lok, Trine Thorborg; Larsen, Helle K.; Kjær, Susanne K.

I: Transplant Infectious Disease, Bind 25, Nr. 2, e14019, 2023.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ring, LL, Thomsen, LT, Hædersdal, M, Sørensen, SS, Bonde, JH, Lok, TT, Larsen, HK & Kjær, SK 2023, 'Prevalence of cervical human papillomavirus and the risk of anal co-infection in kidney transplant recipients: Results from a Danish clinical study', Transplant Infectious Disease, bind 25, nr. 2, e14019. https://doi.org/10.1111/tid.14019

APA

Ring, L. L., Thomsen, L. T., Hædersdal, M., Sørensen, S. S., Bonde, J. H., Lok, T. T., Larsen, H. K., & Kjær, S. K. (2023). Prevalence of cervical human papillomavirus and the risk of anal co-infection in kidney transplant recipients: Results from a Danish clinical study. Transplant Infectious Disease, 25(2), [e14019]. https://doi.org/10.1111/tid.14019

Vancouver

Ring LL, Thomsen LT, Hædersdal M, Sørensen SS, Bonde JH, Lok TT o.a. Prevalence of cervical human papillomavirus and the risk of anal co-infection in kidney transplant recipients: Results from a Danish clinical study. Transplant Infectious Disease. 2023;25(2). e14019. https://doi.org/10.1111/tid.14019

Author

Ring, Linea Landgrebe ; Thomsen, Louise T. ; Hædersdal, Merete ; Sørensen, Søren Schwartz ; Bonde, Jesper Hansen ; Lok, Trine Thorborg ; Larsen, Helle K. ; Kjær, Susanne K. / Prevalence of cervical human papillomavirus and the risk of anal co-infection in kidney transplant recipients : Results from a Danish clinical study. I: Transplant Infectious Disease. 2023 ; Bind 25, Nr. 2.

Bibtex

@article{835fc5cd9b05420da8c721f82eb277c8,
title = "Prevalence of cervical human papillomavirus and the risk of anal co-infection in kidney transplant recipients: Results from a Danish clinical study",
abstract = "Background: Kidney transplant recipients (KTRs) have increased risk of human papillomavirus (HPV)-related cancers, including cervical and anal cancer. In this cross-sectional clinical study, we investigated the prevalence of cervical high-risk HPV (hrHPV) and low-risk (lrHPV), risk factors for cervical hrHPV infection, and the prevalence of cervical and anal hrHPV co-infection in KTRs and immunocompetent controls. Methods: During 2016–2017, we recruited 125 female KTRs and 125 female immunocompetent controls from one dermatology department (KTRs and controls) and five nephrology departments (KTRs) in Denmark. Liquid-based cervical and anal cytology samples were tested for HPV DNA using the INNO-LiPA test and participants answered a questionnaire on lifestyle. Odds ratios (ORs) were estimated using logistic regression, adjusting for age, lifetime sexual partners, smoking, and (in models concerning anal HPV) receptive anal sex. Results: KTRs had higher prevalence of cervical hrHPV than controls (35.5% vs. 18.2; ORadjusted = 2.9, 95% CI, 1.5–5.5). In contrast, the prevalence of lrHPV was similar in KTRs and controls (25.6% vs. 23.1; ORadjusted = 1.2, 95% CI, 0.7‒2.3). KTRs were more likely than controls to have cervical and anal hrHPV co-infection (27.3% vs. 6.6%, ORadjusted = 6.3, 95% CI, 2.7–15.0). Conclusions: Female KTRs had high prevalence of cervical hrHPV, and co-infection with anal and cervical hrHPV was common. Our results underline that KTRs are an important target group for preventive efforts against HPV-related diseases. (Figure presented.).",
keywords = "anus, cervix, co-infection, human papillomavirus, kidney transplantation, prevalence",
author = "Ring, {Linea Landgrebe} and Thomsen, {Louise T.} and Merete H{\ae}dersdal and S{\o}rensen, {S{\o}ren Schwartz} and Bonde, {Jesper Hansen} and Lok, {Trine Thorborg} and Larsen, {Helle K.} and Kj{\ae}r, {Susanne K.}",
note = "Publisher Copyright: {\textcopyright} 2023 The Authors. Transplant Infectious Disease published by Wiley Periodicals LLC.",
year = "2023",
doi = "10.1111/tid.14019",
language = "English",
volume = "25",
journal = "Transplant Infectious Disease",
issn = "1398-2273",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Prevalence of cervical human papillomavirus and the risk of anal co-infection in kidney transplant recipients

T2 - Results from a Danish clinical study

AU - Ring, Linea Landgrebe

AU - Thomsen, Louise T.

AU - Hædersdal, Merete

AU - Sørensen, Søren Schwartz

AU - Bonde, Jesper Hansen

AU - Lok, Trine Thorborg

AU - Larsen, Helle K.

AU - Kjær, Susanne K.

N1 - Publisher Copyright: © 2023 The Authors. Transplant Infectious Disease published by Wiley Periodicals LLC.

PY - 2023

Y1 - 2023

N2 - Background: Kidney transplant recipients (KTRs) have increased risk of human papillomavirus (HPV)-related cancers, including cervical and anal cancer. In this cross-sectional clinical study, we investigated the prevalence of cervical high-risk HPV (hrHPV) and low-risk (lrHPV), risk factors for cervical hrHPV infection, and the prevalence of cervical and anal hrHPV co-infection in KTRs and immunocompetent controls. Methods: During 2016–2017, we recruited 125 female KTRs and 125 female immunocompetent controls from one dermatology department (KTRs and controls) and five nephrology departments (KTRs) in Denmark. Liquid-based cervical and anal cytology samples were tested for HPV DNA using the INNO-LiPA test and participants answered a questionnaire on lifestyle. Odds ratios (ORs) were estimated using logistic regression, adjusting for age, lifetime sexual partners, smoking, and (in models concerning anal HPV) receptive anal sex. Results: KTRs had higher prevalence of cervical hrHPV than controls (35.5% vs. 18.2; ORadjusted = 2.9, 95% CI, 1.5–5.5). In contrast, the prevalence of lrHPV was similar in KTRs and controls (25.6% vs. 23.1; ORadjusted = 1.2, 95% CI, 0.7‒2.3). KTRs were more likely than controls to have cervical and anal hrHPV co-infection (27.3% vs. 6.6%, ORadjusted = 6.3, 95% CI, 2.7–15.0). Conclusions: Female KTRs had high prevalence of cervical hrHPV, and co-infection with anal and cervical hrHPV was common. Our results underline that KTRs are an important target group for preventive efforts against HPV-related diseases. (Figure presented.).

AB - Background: Kidney transplant recipients (KTRs) have increased risk of human papillomavirus (HPV)-related cancers, including cervical and anal cancer. In this cross-sectional clinical study, we investigated the prevalence of cervical high-risk HPV (hrHPV) and low-risk (lrHPV), risk factors for cervical hrHPV infection, and the prevalence of cervical and anal hrHPV co-infection in KTRs and immunocompetent controls. Methods: During 2016–2017, we recruited 125 female KTRs and 125 female immunocompetent controls from one dermatology department (KTRs and controls) and five nephrology departments (KTRs) in Denmark. Liquid-based cervical and anal cytology samples were tested for HPV DNA using the INNO-LiPA test and participants answered a questionnaire on lifestyle. Odds ratios (ORs) were estimated using logistic regression, adjusting for age, lifetime sexual partners, smoking, and (in models concerning anal HPV) receptive anal sex. Results: KTRs had higher prevalence of cervical hrHPV than controls (35.5% vs. 18.2; ORadjusted = 2.9, 95% CI, 1.5–5.5). In contrast, the prevalence of lrHPV was similar in KTRs and controls (25.6% vs. 23.1; ORadjusted = 1.2, 95% CI, 0.7‒2.3). KTRs were more likely than controls to have cervical and anal hrHPV co-infection (27.3% vs. 6.6%, ORadjusted = 6.3, 95% CI, 2.7–15.0). Conclusions: Female KTRs had high prevalence of cervical hrHPV, and co-infection with anal and cervical hrHPV was common. Our results underline that KTRs are an important target group for preventive efforts against HPV-related diseases. (Figure presented.).

KW - anus

KW - cervix

KW - co-infection

KW - human papillomavirus

KW - kidney transplantation

KW - prevalence

U2 - 10.1111/tid.14019

DO - 10.1111/tid.14019

M3 - Journal article

C2 - 36695181

AN - SCOPUS:85147499643

VL - 25

JO - Transplant Infectious Disease

JF - Transplant Infectious Disease

SN - 1398-2273

IS - 2

M1 - e14019

ER -

ID: 359318864